Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
about
Exposure to bisphenol A correlates with early-onset prostate cancer and promotes centrosome amplification and anchorage-independent growth in vitroTestosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.Is there an association between serum prostate-specific antigen values and serum testosterone levels in healthy men?Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.The development of prostate cancer despite late onset androgen deficiency.Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?Androgen therapy: testing before prescribing and monitoring during therapy.Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism.Testosterone replacement therapy and prostate cancer: a word of caution.Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.Differing levels of testosterone and the prostate: a physiological interplay.Testosterone replacement and prostate cancer.Serum testosterone level, testosterone replacement treatment, and prostate cancer.Update on Testosterone Replacement Therapy in Hypogonadal Men.Exogenous testosterone: a preventable cause of male infertility.Association between Serum Testosterone and PSA Levels in Middle-Aged Healthy Men from the General Population.The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men.Prostate cancer following testosterone replacement in Klinefelter syndrome.Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis.Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer.
P2860
Q21132302-1873DA36-ACC1-471E-A14B-D6CD148AD8F9Q33276072-FA7E9079-7B0E-4A08-9FE7-6A7C7C597FD0Q33911747-E96A43D7-331B-48F3-AC4B-7870FFB29B65Q35117241-47F471A6-755C-4CC8-ADD2-B18951154BE6Q35223564-85434104-43FB-4AD5-BD97-271536E3FA2EQ36275532-9BDFD8BE-9DEC-442E-8E51-465E818C3C5CQ36303823-1E540BE7-DC8E-4E73-B799-D6803CD74FF0Q36440341-17EC36A6-932C-44C0-A1CB-60686B0818CFQ36488885-64AC1D49-47F8-4382-9553-6D8F6E9D3A42Q36801735-A56C38EF-2426-4619-9690-7497B9E39A3BQ37218685-502153D6-BF5D-4FD1-925C-5E6004A7AF83Q37883014-5FA8CF83-BF20-4BC1-BA24-0E06C22E489BQ38037508-48E40E9D-6809-47E4-9A78-4D79E9FD6392Q38155496-CC017777-4C7D-43E6-B0FF-DE2165B68FB3Q38528376-C71EC6FE-696B-4A4B-AE1F-F77F43DAC213Q38712661-38AE8E3F-61DC-4555-9548-8411CD08E34CQ38755381-DC943817-0848-43FC-8AC2-0F5352E2E847Q39280815-EF906BFE-14D1-4283-8895-35ED76A26466Q39786449-A329823A-373F-4559-8FE2-8AA8C5AC473DQ46715554-8BD4A741-A175-418B-8C07-4BBD9954E3EAQ47108979-7B0B4F02-E166-4040-BE79-D8D280F1F0A1Q54970093-A507B6AF-FB8E-47C5-BC98-61C608BF3C5E
P2860
Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@en
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@nl
type
label
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@en
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@nl
prefLabel
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@en
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@nl
P2093
P356
P1433
P1476
Testosterone treatment in hypo ...... l and risk of prostate cancer.
@en
P2093
P304
P356
10.4158/EP.6.2.132
P577
2000-03-01T00:00:00Z